Table 2. Gastrointestinal clinical manifestations in HIV-associated disseminated histoplasmosis: nature and prevalence.
Variable | n/N all patients with gastrointestinal signs and symptoms (%) | n/N patients without any other concomitant opportunistic infection (%) | n/N patients with a positive diagnosis on a gastrointestinal sample (%) |
---|---|---|---|
Abdominal pain | 124/245 (50.6) | 76/150 (50.7) | 48/65 (73.8) |
Diarrhea | 123/245 (50.2) | 76/150 (50.7) | 46/65 (70.8) |
mucoid-bloody /watery diarrhea | 21/122 (17.2) | 11/65 (14.5) | 8/37 (17.8) |
Liver enlargement | 98/245 (40.0) | 62/150 (41.3) | 16/65 (24.6) |
Splenomegaly | 56/245 (22.8) | 34/150 (22.7) | 7/65 (10.8) |
Anal lesions | 9/245 (3.6) | 7/150 (4.7) | 2/65 (3.1) |
Digestive complications | 24/245 (9.8) | 16/150 (10.7) | 10/65 (15.4) |
Ascites | 9/245 (3.7) | 7/150 (4.7) | 3/65 (4.6) |
Hemorrhage | 7/24 (2.9) | 5/150 (3.2) | 3/65 (4.6) |
Dysphagia | 3/245 (1.2) | 2/150 (1.3) | 0/65 (0) |
Subocclusion | 2/245 (0.8) | 2/150 (1.3) | 2/65 (3.1) |
Perforation | 1/245 (0.4) | 0/150 (0) | 1/65 (1.5) |
Vomiting+++ | 1/245 (0.4) | 0/150 (0) | 0/65 (0) |
Appendixectomy+right colonectomy | 1/245 (0.4) | 0/150 (0) | 1/65 (1.5) |
Peritonitis | 1/245 (0.4) | 0/150 (0) | 1/65 (1.5) |
Abdominal mass | 1/245 (0.4) | 1/150 (0.7) | 1/65 (1.5) |